|
IdoA2S-GlcNS6S, 4Na (I2S6)
|
|
|
|
IFN-beta, Mouse, Recombinant (CHO-derived), 5 x 10E4 units
|
|
|
|
IdoA-GlcNS6S, 3Na (I0S6)
|
|
|
|
i-Fect
|
|
|
|
IFN-alpha, Mouse, mAb F18, 100 ug
|
|
|
|
IdoA2S-GlcNS, 3Na (I2S0)
|
|
|
|
IgG1, Mouse, mAb MOPC-21, Isotype control, R-PE, 25 ug
|
|
|
|
IFN-gamma, Human, mAb F12, 300 ug
|
|
|
|
IDO1, Rat, pAb, 100 ug
|
|
|
|
IgG1, Ms, mAb MOPC-21, Isotype ctrl, Ultra Low Endotox, 1 mg
|
|
|
|
IgG2a, Rat, mAb RTK2758, Isotype control, 50 ug
|
|
|
|
IdoA-GlcNS, 2Na (I0S0)
|
|
|
|
ICAM-3, Human Recombinant
|
|
|
|
IgG1, Ms, mAb MOPC-21, Isotype ctrl, Low Endotoxin, 500 ug
|
|
|
|
IgG2a, Rat, mAb RTK2758, Isotype ctrl, Low Endotoxin, 500 ug
|
|
|
|
IL-FABP, Human, pAb, 100 ug
|
|
|
|
IL-12 (Interleukin 12) GMP, CF
|
|
|
|
IL-10, Human, pAb, 20 ug
|
|
|
|
IL-5, murine recombinant
|
|
|
|
IL-20, mouse recombinant
|
|
|
|
IL-FABP, Human, pAb, 20 ug
|
|
|
|
IL-7 GMP, CF
|
|
|
|
IL-33, Human, pAb, 100 ul
|
|
|
|
Immunoglobulin E(IgE) human serum (3rd International Standard)
|
|
|
|
IMEMS Random Nanofibers 6 Chambers
|
|
|
|
IL-22, Human, pAb, 100 ul
|
|
|
|
IL-12B p40, Human, pAb, 100 ul
|
|
|
|
IGRP Catalytic Subunit (206-214)
|
|
|
|
IL-6/IL-6R alpha, Chimera
|
|
|
|
IL-15 GMP, CF
|
|
|
|
Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent
|
|
|
|
Influenza antiserum A/Anhui/1/05 (H5)
|
|
|
|
Influenza anti A/Panama/2007/99 Serum
|
|
|
|
Interleukin-1 alpha (Human rDNA derived) WHO International Standard
|
|
|
|
Influenza Antigen A/Texas/36/91
|
|
|
|
Influenza anti A/Philippine/2/82 Serum
|
|
|
|
Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
|
|
|
|
Ins(1,3,4,5)P4 Beads
|
|
|
|
JAM-A, domain 2, Human, pAb, 20 ug
|
|
|
|
Influenza Antigen B/Yamanashi/166/98
|
|
|
|
JA | Jasmonic acid
|
|
|
|
Interleukin-6 (Human, rDNA derived) WHO International Standard
|
|
|
|
Jacalin-Sepharose
|
|
|
|
IRL 1620 (Endothelin B Receptor Agonist)
|
|
|
|
Internal Standard, lyophil., for Mycophenolic Acid for TDM Platform, Add-on Set-order no. MS99100
|
|
|
|
Isovaleric-d9 acid ≥98 atom % D, ≥97% (CP)
|
|
|
|
Influenza Virus infectious A/Sichuan/346/98 (H3N2)
|
|
|
|
IndividualCalibrationSolutions
|
|
|
|
Influenza Antigen A/Brazil/11/78
|
|
|
|
Influenza Virus Infectious B/Maryland/15/2016 42800 E5
|
|
|
|
Influenza Virus infectious NIB-27 (H1N1)
|
|
|
|
Influenza Antigen A/New Caledonia/20/99
|
|
|
|
Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)
|
|
|
|
Interleukin-2 Soluble Receptor (human, rDNA derived)
|
|
|
|
JAM-A, domain 1, Human, pAb, 20 ug
|
|
|
|
JAM-A, domain 2, Human, pAb, 100 ug
|
|
|
|
Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
|
|
|
|
JAM-A, domain 1, Human, pAb, 100 ug
|
|
|
|
Interferon alpha (Human, leukocyte derived)WHO International Standard
|
|
|
|
Internal Standard IS, lyophil. for Vitamins B1, B2, B6 in Whole Blood (MS13000)
|
|
|
|
Internal Standard Epimers-Mix
|
|
|
|
Influenza anti B/ Neuraminidase Serum
|
|
|
|
Laminin Rhodamine (mouse tumor)
|
|
|
|
Lactoferrin, Bovine, pAb, 20 ug
|
|
|
|
Lipopolysaccharides from Salmonella livingstone
|
|
|
|
LL-37/CAP-18, Human, mAb 3D11, 100 ug
|
|
|
|
KatG | catalase peroxidase (HPI), cyanobacterial
|
|
|
|
Lipopolysaccharides from Salmonella essen
|
|
|
|
LBP, Mouse, ELISA kit, 1 x 96 det.
|
|
|
|
Labeled N-Glycans,
|
|
|
|
Lipid A from E.coli, Serotype R515 (Re), 1 mg
|
|
|
|
KLH | Keyhole limpet hemocyanin, HRP-conjugated (40 µg)
|
|
|
|
L-Methionine-13C5,15N,2,3,3,4,4-d5-(methyl-d3) 99 atom % 13C, 98 atom % 15N, 98 atom % D, 95% (CP)
|
|
|
|
L-Carnitine-(methyl-13C,d3) hydrochloride 99 atom % 13C, 98 atom % D, 97% (CP)
|
|
|
|
KCNK2/TREK-1 Blocking Peptide
|
|
|
|
Lhca1 | PSI type I chlorophyll a/b-binding protein
|
|
|
|
Laminin HiLyte488™ (mouse tumor)
|
|
|
|
LewisY Blood Antigen/BG8
|
|
|
|
K-Ras4B Mutant Protein: G13S (human recombinant with 6xHis-tag)
|
|
|
|
Lipopolysaccharides from Actinobacillus pleuropneumoniae
|
|
|
|
KCNN3/KCa2.3 Blocking Peptide
|
|
|
|
Lipopolysaccharide Core, mAb WN1 222-5, 20 ug
|
|
|
|
LL-37, Human, ELISA kit, 1 x 96 det.
|
|
|
|
Lipid A from Salmonella minnesota, R595 (Re), 1 mg
|
|
|
|
LowRanger 100bp DNA Ladder
|
|
|
|
Lactoferrin, Human, pAb, 20 ug
|
|
|
|
LC-3 Pesticides Mix 17 each 50μg/mL in Methanol
|
|
|
|
Labeled ds miRNA mimics Neg Control
|
|
|
|
LAIR-1, Human, mAb NKTA255, 500 ug
|
|
|
|
KDEL | endoplasmic reticulum retention signal, ATTO 390 conjugated
|
|
|
|
Lipoproteins, Very Low Density, Human Plasma, Suitable for Cell Culture
|
|
|
|
Laminin Biotin (mouse tumor)
|
|
|
|
LAL Chromogenic Endpoint Assay, 3 x 96 det.
|
|
|
|
Lipopolysaccharides from Escherichia coli O145
|
|
|
|
K-Ras4B Mutant Protein: K128A (human recombinant with 6xHis-tag)
|
|
|
|
KChIP2 Blocking Peptide
|
|
|
|
Latrophilin-1/LPHN1 Blocking Peptide
|
|
|
|
Lactoferrin, Human, pAb, 100 ug
|
|
|
|
Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
|
|
|
|
KCNK13/THIK-1 Blocking Peptide
|
|
|